Some 25 years ago, a young Parkinson's disease investigator, Robert Hauser, MD, stepped to the podium at an American Academy ...

A cough medicine used for decades in Europe called Ambroxol has shown promise for treating dementia in people with ...

A drug used for Parkinson's disease has been shown to be effective in reducing the symptoms of difficult to treat depression, ...

Simon Fraser University researchers are using a new approach to brain imaging that could improve how drugs are prescribed to ...

Researchers at Lawson Research Institute (Lawson), the research arm of St. Joseph's Health Care London, are investigating ...

After presentations to the International Linked Clinical Trials (iLCT), which was set up by Cure Parkinson’s over a decade ...

Parkinson’s disease is primarily distinguished by resting tremors, bradykinesia, muscle rigidity, and balance issues, all of which have a substantial influence on patients' quality of life. Although ...

Researchers at Simon Fraser University reveal how brain imaging techniques can explain the inconsistent effects of levodopa ...

Drastic cuts to NIH will halt brain research on the cusp of transformational treatments. These setbacks could derail future ...

Understand Parkinson's disease, its symptoms, and the crucial role of clinical trials in treatment and research, especially for Black Americans.

Scientists are to examine whether drugs that are already in use could be repurposed to treat the symptoms of both Alzheimer’s ...

Ambroxol chaperones GCase; in a previous study of people with Parkinson's disease, the drug led to increased GCase levels. It ...